Zimbabwe has rejected a major US healthcare agreement worth $367m (£272m) over five years over Washington's request for sensitive biological samples.
The decision became public after a government memo from December was leaked, indicating that President Emmerson Mnangagwa felt the agreement was "lopsided".
An official representative later stated that the United States was seeking biological samples for research and commercial gain while was not willing to share the benefits from any future medical innovations.
"We will now turn to the challenging and unfortunate task of ending our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy noted the US had donated over $1.9bn as health assistance to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has called for further talks to secure a agreement acceptable to all parties so the country's critical HIV treatment initiative can be sustained.
Broader Implications
This rejection comes after a comparable case in neighbouring Kenya, where a high court blocked a related deal with the US following legal challenges were filed about the safety of Kenyans' health data.
Since returning to office last year, US President Donald Trump has drastically cut foreign aid and closed the US Agency for International Development (USAID).
USAID had managed assistance for the US government, but Trump stated its expenditure was "inefficient" and his government was pursuing government-to-government agreements to enhance openness and responsibility.
As per statements, Sixteen African countries have so far agreed to similar agreements, representing more than $18.3bn of fresh investment.
Specifics of the Rejected Agreement
This assistance for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this cooperation would have delivered extraordinary advantages for Zimbabwean communities, particularly the 1.2 million currently on antiretroviral therapy through US-supported initiatives," the Ambassador commented.
However, official spokesman Nick Mangwana argued the proposed deal was "unequal".
"Our nation was requested to provide its genetic material and health information for a long time, without any equivalent promise of access to any medical innovations – like new medicines or tests – that might result from that provided information," Mangwana explained.
"Put simply, our country would supply the basic resources for medical research with no certainty that the end products would be available to our people if a future health crisis emerge."
National Interest and International Frameworks
He also said that the American exit from the World Health Organization (WHO) and its push of bilateral health agreements were disrupting structures previously established through the international health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing scheme designed to deal with future global health emergencies.
"This mechanism is designed to guarantee that when a nation contributes its data, the benefits – such as vaccines and treatments – are distributed fairly, not commercialised solely by those with the resources to create them."
The government's concerns over the US deal "must not be interpreted as opposition to America," he added.
"We welcome ongoing discussions with our US partners on how future co-operation could be arranged in a way that respects the independence and dignity of both nations."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it acknowledged the official position, but suggested that negotiations need to persist given that a large portion of the nation's Aids initiatives relied on international support.
"In cases where technical issues arise, including those involving data governance or agreement terms, these can often be addressed through technical clarification and negotiated safeguards," it added.
This impasse underscores the complex challenges between accepting crucial foreign assistance and safeguarding national sovereignty in an ever more interconnected world.